Clofibrate in icter
Not Applicable
- Conditions
- eonatal jaundice.Neonatal jaundice, unspecified
- Registration Number
- IRCT201008172639N3
- Lead Sponsor
- Shaheed Sadoughi University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Gestation age of 38-42 weeks, Birth weight of 2500-4000 grams, Product of normal vaginal delivery, Bilirubin level of 17-29.9 mg/dL
Exclusion criteria: Neonates with sepsis, anemia and hemolytic diseases, indirect hyperbilirubinemia, underlying hepatic disorders
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total serum bilirubin level. Timepoint: 12, 24, and 48 hours after beginning of the treatment. Method of measurement: laboratory analysis.
- Secondary Outcome Measures
Name Time Method Hospital stay. Timepoint: in days. Method of measurement: counting of stay days based on medical records.;Time of treatment with phototherapy. Timepoint: At the end of the treatment. Method of measurement: review of medical record.;Side effects. Timepoint: during hospital stay and on the second day after discharge. Method of measurement: clinical evaluation.